ANS Pharmacology & Pathophysiology 2 Flashcards

1
Q

Which is NOT an endogenous sympathomimetic?
a. ephedrine
b. dopamine
c. norepinephrine
d. epinephrine

A

a. ephedrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Endogenous catecholamines include

A

epinephrine, norepinephrine, and dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Synthetic catecholamines include

A

dobutamine
isoproterenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Endogenous and synthetic catecholamines may produce

A

hypertension
arrhythmias
myocardial ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The effects of endogenous and synthetic agonists are dependent on their

A

specificity for alpha and beta adrenoreceptors and dopaminergic subtypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the classification of ephedinre?

A

synthetic noncatecholamine
sympathomimetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Administration of beta 2 adrenoreceptors agonists in aerosolized form minimizes

A

side effects such as anxiety, tremor, and restlessness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Isoproterenol and dobutamine have _________ activity

A

beta 1 and some beta 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Epinephrine and norepinephrine undergo metabolism by

A

catechol-O-methyl transferase and monoamine oxidase to yield vanillymandelic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

_________ is assayed as part of the diagnostic work-up of pheochromocytoma

A

VMA or vanillymandelic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Adrenergic agonists mimic ___________ effects via

A

SNS; direct receptor activation or by encouraging endogenous catecholamine release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the receptor and dosing of epinephrine?

A

B1>B2, alpha 1
0.01-0.2 mcg/kg/min.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the receptor and dosing of norepinephrine?

A

alpha 1, beta 1>beta 2
0.01-0.2 mcg/kg/min.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the receptor and dosing of dopamine?

A

beta 1>beta 2, alpha 1
2-20 mcg/kg/min.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the receptor and dosing of isoproterenol?

A

B1>B2
0.015-0.15 mcg/kg/min.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the receptor and dosing of dobutamine?

A

B1>B2>A1
2-20 mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the receptor and dosing of ephedrine?

A

a, beta indirect
bolus 5-25 mg IV
up to 50 mg IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the systemic effects of catecholamines?

A

decreased digestive system activity
dilation of bronchioles
increased heart rate
liver converts glycogen to glucose
high blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Epinephrine has more potency at beta receptors than

A

norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The net effect of epi depends on the balance of the receptor types in the individual tissues and organs. Organs with a higher incidence of B2 receptors such as skeletal muscle will see

A

vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

With epinephrine, organs with a higher incidence of alpha 2 receptors such as the mesentery and kidneys will experience

A

vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The net effect of epinephrine depends on the

A

dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Low doses of epinephrine favor

A

beta stimulation (increased HR, CO, inotropy, and pulse pressure, and a decrease in SVR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

High doses of epinephrine favor

A

alpha effects (increased SVR and decreased CO)

25
Significant metabolic changes related to epinephrine administration include
increase in blood glucose hypokalemia occurs due to a transcellular potassium shift
26
Norepinephrine has mostly_________ effects and minimal _______ effects
alpha 1 and beta 1; beta 2
27
Describe the differences in receptor affinity with high doses of norepinephrine versus low.
low doses favor B1 stimulation high doses favor beta 1 and alpha effects
28
The systemic vasoconstriction effect of norepinephrine is _________ epinephrine
greater
29
Describe how the does of dopamine stimulates different receptors.
low dose dopamine (<3 mcg/kg/min) stimulates D1 receptors moderate doses of dopamine (3-8 mcg/kg/min) stimulate alpha1 and beta 1 adrenergic receptors in the heart and periphery high dose dopamine (>10 mcg/kg/min) acts a a pure alpha 1 agonist
30
Postsynaptic D1 receptors cause
vasodilation of renal, GI, coronary, and cerebral vessels
31
Presynaptic D2 receptors
inhibit norepinephrine release and thus cause vasodilation
32
Dopamine ___________ prevent or reverse AKI or failure
Does NOT
33
Dopamine undergoes what kind of metabolism?
metabolic degradation by catechol-O-methyl transferase and MAO (same as norepi & epi!)
34
The end product of dopamine metabolism is
homovanillic acid
35
Isoproterenol is derived from
dopamine
36
IV infusion dose of isoproterenol is
0.015-0.15 mcg/kg/min.
37
What is the MOA of isoproterenol?
potent sympathomimetic with B1 and B2 activity (2-3x potency of epinephrine)
38
What can isoproterenol precipitate?
supraventricular and ventricular arrhythmias
39
What does dobutamine do?
enhances myocardial contractility and reduces vascular tone
40
What is the IV infusion dose of dobutamine?
2-20 mcg/kg/min.
41
Uses of dobutamine include:
inotropic agent in those with pulmonary hypertension (beta 2 stimulation reduces pulmonary vascular resistance) potent inotrope that may be used in select cases of heart disease, MI, and depressed myocardial states dobutamine stress echo to assess heart function during exertion
42
What is the MOA of dobutamine?
selective b1 agonist with mild B2 effects
43
Adverse effects of dobutamine include
extending cardiac muscle infarction increasing AV conduction which can trigger rapid ventricular rate in those with A-fib
44
What is the drug class of ephedrine?
synthetic, noncatecholamine sympathomimetic
45
What receptors does ephedrine stimulate?
both alpha and beta receptors (indirect agent as well)
46
_______________ is seen with repeat administrations of ephedrine due to ____________
tachyphylaxis; due to depletion of presynaptic norepinephrine
47
Ephedrine has mild stimulating effects because
it crosses the BBB
48
Short-acting beta 2 agonist drugs include
albuterol terbutaline levalbuterol
49
Long-acting B2 agonist drugs include
salmetrol formoterol
50
An FDA "black box" warning is attached to the
longer-acting B2-selective agents (salmeterol & formoterol) d/t risk of asthma-related death -possibly d/t development of airway hyperresponsiveness
51
What effect does beta 2 agonists have on the uterus?
increased cAMP leading to decreased Ca2+ levels--> uterine smooth muscle relaxation and a tocolytic effect
52
With escalated doses of B2 agonists over time, the B2
selectivity wanes, and B2 effects such as tachycardia and arrhythmias may become apparent
53
Chronic B2 agonist therapy can lead to
down-regulation of the target receptors resulting in tachyphylaxis also evidence of airway hyperresponsiveness
54
What potent alpha agonist is the chemical precursor of epinephrine?
norepinephrine
55
Which adrenoreceptor agonist is metabolized by the liver?
ephedrine
56
Which synthetic catecholamine is derived from dopamine?
isoproterenol
57
Which drug has the greatest increase in MAP?
norepinephrine
58
Which drug is the precursor of norepinephrine?
dopamine
59
Which drug results in a large increase of renal blood flow?
dopamine